Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma in Older Patients”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Not applicableStudy completedNCT03508765
What this trial is testing

Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 18
Not applicableStudy completedNCT00003196
What this trial is testing

Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+33 more
Fred Hutchinson Cancer Center 63
Not applicableLooking for participantsNCT06247189
What this trial is testing

ICOPE Program Feasibility in the Management of Myeloma Patients

Who this might be right for
FrailtyMultiple Myeloma
University Hospital, Toulouse 30
Large-scale testing (Phase 3)Study completedNCT00443235
What this trial is testing

GEM05 for Patients With Multiple Myeloma More Than 65 Years Old

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 260
Testing effectiveness (Phase 2)Ended earlyNCT00113919
What this trial is testing

UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
University of Arkansas 14
Large-scale testing (Phase 3)UnknownNCT00002653
What this trial is testing

Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Medical Research Council 1,000
Early research (Phase 1)Active Not RecruitingNCT05823571
What this trial is testing

Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients

Who this might be right for
Leukemia, AcuteMyelodysplastic SyndromesMyelomonocytic Leukemia, Chronic+5 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Testing effectiveness (Phase 2)Study completedNCT00388635
What this trial is testing

Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 60
Not applicableLooking for participantsNCT06145581
What this trial is testing

Remote Monitoring With Health-Coaching to Improve Quality of Life in Older Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Mayo Clinic 25
Not applicableLooking for participantsNCT04300998
What this trial is testing

Study of CAR-T Therapy in Older Patients

Who this might be right for
LymphomaRefractory B-Cell LymphomaLymphoma, B-Cell+3 more
Memorial Sloan Kettering Cancer Center 154
Not applicableLooking for participantsNCT07674498
What this trial is testing

Immune Fitness in Older Patients With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Myeloma Multiple
Jules Bordet Institute 31
Testing effectiveness (Phase 2)WithdrawnNCT02082405
What this trial is testing

Bortezomib, Dexamethasone, and Cyclophosphamide in Treating Older Patients With Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06597916
What this trial is testing

RSV Vaccination in Immunocompromised Patients.

Who this might be right for
RSV Infection
Medical University of Vienna 200
Early research (Phase 1)Ended earlyNCT00934232
What this trial is testing

Busulfan in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Guido Tricot 13
Testing effectiveness (Phase 2)Ended earlyNCT01453088
What this trial is testing

Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 63
Not applicableLooking for participantsNCT07309497
What this trial is testing

Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)

Who this might be right for
Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaCART TherapyBispecific Antibody+1 more
University of Zurich 208
Early research (Phase 1)Study completedNCT02135406
What this trial is testing

CART-19 for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Pennsylvania 13
Not applicableEnded earlyNCT07045727
What this trial is testing

Prehabilitation With Aerobic and Resistance Exercise for Improving Physical Fitness and Quality of Life Outcomes in Older Patients Undergoing CAR-T Therapy for Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Mayo Clinic 12
Testing effectiveness (Phase 2)Looking for participantsNCT05145400
What this trial is testing

Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaCancer
UNC Lineberger Comprehensive Cancer Center 50
Not applicableStudy completedNCT00296023
What this trial is testing

Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
University of California, San Francisco 25
Next Page